Solar projects boom but some fear a bubble
Solar installers boomed in 2013 and are expecting another good year, but some are skeptical about the new financial models underlying the growth numbers.
Read More →Amgen profits hit $5B, beat expectations
The biotech company recorded earnings per share of $7.60, well above the $7.46 expected by a survey of 27 analysts by Thomson Reuters.
Read More →Ceres files for $20M offering
The Thousand Oaks-based firm said it would like to use the proceeds from the public offering to expand its Brazilian operations, participate in collaborations and break into new markets.
Read More →Teledyne shares dip despite jump in Q4 profits
Shares of defense and industrial conglomerate Teledyne Technologies sank 1.6 percent in midday trading on Thursday despite higher sales and profits from the Thousand Oaks-based firm.
Read More →Amgen enters into deals for colon cancer, IBD treatments
Thousand Oaks-based Amgen has entered into two new collaborations, one involving treatment for colon cancer and another regarding therapies for inflammatory bowel disease.
Read More →
Sponsored content:
2015-2016 Giving Guide
